BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 19544481)

  • 1. De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.
    Kang SJ; Won HS; Choi WS; Lee BJ
    J Pept Sci; 2009 Sep; 15(9):583-8. PubMed ID: 19544481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo generation of short antimicrobial peptides with simple amino acid composition.
    Lee SH; Kim SJ; Lee YS; Song MD; Kim IH; Won HS
    Regul Pept; 2011 Jan; 166(1-3):36-41. PubMed ID: 20736034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
    Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
    Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.
    Gopal R; Park SC; Ha KJ; Cho SJ; Kim SW; Song PI; Nah JW; Park Y; Hahm KS
    J Pept Sci; 2009 Sep; 15(9):589-94. PubMed ID: 19642077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide.
    Ando S; Mitsuyasu K; Soeda Y; Hidaka M; Ito Y; Matsubara K; Shindo M; Uchida Y; Aoyagi H
    J Pept Sci; 2010 Apr; 16(4):171-7. PubMed ID: 20196123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
    Zhu WL; Hahm KS; Shin SY
    J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.
    Kim SJ; Kim JS; Lee YS; Sim DW; Lee SH; Bahk YY; Lee KH; Kim EH; Park SJ; Lee BJ; Won HS
    Molecules; 2013 Jan; 18(1):859-76. PubMed ID: 23344198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of short arginine- and tryptophan-rich peptides.
    Strøm MB; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Aug; 8(8):431-7. PubMed ID: 12212806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial activity of dermaseptin S1 analogues.
    Savoia D; Guerrini R; Marzola E; Salvadori S
    Bioorg Med Chem; 2008 Sep; 16(17):8205-9. PubMed ID: 18676150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.
    Cerovský V; Hovorka O; Cvacka J; Voburka Z; Bednárová L; Borovicková L; Slaninová J; Fucík V
    Chembiochem; 2008 Nov; 9(17):2815-21. PubMed ID: 18942691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects and mechanisms of physiological conditions on the activity of enantiomeric forms of an α-helical antibacterial peptide against bacteria.
    Huang J; Hao D; Chen Y; Xu Y; Tan J; Huang Y; Li F; Chen Y
    Peptides; 2011 Jul; 32(7):1488-95. PubMed ID: 21664394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity.
    Wei SY; Wu JM; Kuo YY; Chen HL; Yip BS; Tzeng SR; Cheng JW
    J Bacteriol; 2006 Jan; 188(1):328-34. PubMed ID: 16352849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of an indolicidin peptide analogue with increased protease stability.
    Rozek A; Powers JP; Friedrich CL; Hancock RE
    Biochemistry; 2003 Dec; 42(48):14130-8. PubMed ID: 14640680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
    Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
    Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.
    Pál T; Sonnevend A; Galadari S; Conlon JM
    Regul Pept; 2005 Jul; 129(1-3):85-91. PubMed ID: 15927702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tryptophan on lipid binding of linear amphipathic cationic antimicrobial peptides.
    Jin Y; Mozsolits H; Hammer J; Zmuda E; Zhu F; Zhang Y; Aguilar MI; Blazyk J
    Biochemistry; 2003 Aug; 42(31):9395-405. PubMed ID: 12899626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.
    Yu HY; Huang KC; Yip BS; Tu CH; Chen HL; Cheng HT; Cheng JW
    Chembiochem; 2010 Nov; 11(16):2273-82. PubMed ID: 20865718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.